Journal name: World Journal of Pharmaceutical Research
Original article title: Microspheres as drug carriers for targeted drug delivery
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Subtitle: a review
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Rohit and Neha
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Microspheres as drug carriers for targeted drug delivery
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20229-24756
Download the PDF file of the original publication
Summary of article contents:
Introduction
Microspheres have emerged as promising drug carriers in the field of targeted drug delivery, offering a more efficient means of delivering pharmaceuticals to specific sites within the body. Composed of biodegradable polymers, these small particles, typically less than 200 µm in size, can encapsulate various therapeutic agents, including proteins and synthetic materials. With advancements in technology, the versatility of microspheres has expanded, enabling their application in numerous drug administration routes, including oral, parenteral, nasal, and transdermal delivery systems. Their unique properties facilitate controlled drug release, improved absorption, and targeted delivery, ultimately enhancing therapeutic efficacy and patient compliance.
Targeted Drug Delivery Systems
Targeted drug delivery systems aim to concentrate medication at specific sites within the body, thus improving the therapeutic index of drugs while minimizing systemic side effects. Unlike conventional delivery methods, which often distribute drugs throughout the body indiscriminately, targeted systems leverage specific characteristics of the target tissues or cells to direct the delivery of drug-loaded microspheres. This is achieved through passive targeting, where drug carriers accumulate in diseased tissues due to the unique physiological properties of those areas, such as increased vascular permeability, or through active targeting, which involves modifying the carrier's surface with ligands that bind selectively to receptors on target cells. The advancement of these systems offers new avenues in the treatment of diseases, particularly cancer, where traditional therapies have often resulted in significant adverse effects.
Controlled Drug Delivery Systems
Controlled drug delivery systems utilize various mechanisms to maintain predictable and consistent drug release profiles over a specified duration. The key to such systems lies in their ability to modulate pharmacokinetic behavior, aiming for steady drug concentrations within therapeutic ranges. Techniques such as encapsulation in polymers allow for sustained or pulsatile release mechanisms, catering to specific therapeutic needs. The design of these systems often involves integrating stimuli-responsive polymers that can react to changes in the physiological environment, such as pH or temperature, facilitating the release of the drug only at the intended site or under specific conditions. This innovation can significantly improve patient outcomes by ensuring that effective drug levels are maintained in the target area for extended periods.
Recent Advancements in Colonic Drug Delivery
Colonic drug delivery systems represent a specialized form of targeted drug delivery, focusing on the delivery of medications specifically to the colon. This approach is particularly advantageous for treating localized conditions like inflammatory bowel diseases and for enhancing the bioavailability of drugs that undergo extensive first-pass metabolism. Innovations in microsphere technology and formulation strategies, such as pH-sensitive and microbially triggered systems, have been developed to ensure that drugs reach the colon intact, releasing their contents only at the targeted site. Advances also include the use of polysaccharides and polymers that are specifically degraded by colonic bacteria, ensuring localized drug action while limiting systemic exposure and potential side effects.
Conclusion
In summary, the evolution of microspheres as drug carriers has opened up new pathways in pharmaceutical technology, enhancing the efficacy and safety of drug delivery systems. The advancement of targeted and controlled release formulations, particularly in the context of colonic drug delivery, highlights the potential benefits of microspheres in improving therapeutic outcomes. As ongoing research addresses current challenges and explores novel approaches, microspheres are likely to play an increasingly central role in the future of drug delivery, particularly in the treatment of diseases that require precise and effective medication administration. Their success depends on continued innovation in materials science and formulation technology, ultimately leading to better treatment regimens and improved patient care.
FAQ section (important questions/answers):
What are microspheres used for in drug delivery?
Microspheres serve as effective carriers for targeted drug delivery, improving drug release and absorption characteristics while ensuring sustained and controlled release into the body.
Why is oral drug delivery considered the most convenient?
Oral drug delivery offers ease of administration, cost-effectiveness, and patient compliance, despite challenges such as drug degradation and variable absorption rates in the gastrointestinal tract.
What are the advantages of targeted drug delivery systems?
Targeted drug delivery improves drug efficacy by concentrating medication at specific sites in the body, minimizing side effects, and enhancing bioavailability compared to conventional systems.
What challenges exist in developing colonic drug delivery systems?
Challenges include the lower absorption capacity of the colon, variability in gastrointestinal transit times, and the influence of colonic microflora on drug release and efficacy.
What factors influence drug absorption in the colon?
Factors include drug physicochemical properties, colonic residence time, degradation by bacterial enzymes, and the tight junctions in colonic tissues which impact drug transport.
How do pH-sensitive systems aid in drug delivery?
pH-sensitive systems utilize the varying pH levels in the gastrointestinal tract to release drugs specifically when they reach the colon, preventing premature release in the stomach.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Microspheres as drug carriers for targeted drug delivery”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Drug:
This is the plural form of 'drug', encompassing a wide array of chemical substances. Drugs can be classified into various categories such as prescription medications, over-the-counter medications, recreational substances, and natural remedies. The context of their use, such as therapeutic application vs. abuse potential, is vital in healthcare discussions.
2) Disease:
Diseases are pathological conditions that can affect living organisms, characterized by specific symptoms and signs. They can be classified based on their causative agents (infectious vs. non-infectious) or their impact on health (acute vs. chronic). Understanding diseases is vital for effective treatment and prevention strategies.
3) Antibiotic (Antibacterial):
Antibacterial refers to substances that kill or inhibit bacterial growth. In medicine, these agents are crucial for treating infections and preventing bacterial diseases. Research into antibacterial compounds encompasses the study of resistance, efficacy, and innovative formulations in drug development.
4) Water:
Water is an essential solvent in biological systems, facilitating numerous biochemical reactions. It's crucial for drug formulations, influencing drug absorption, solubility, and stability. In medical contexts, hydration plays an important role in overall health and pharmacological action, underscoring its significance in drug delivery systems.
5) Gelatin:
Gelatin is a natural polymer derived from collagen, widely used in pharmaceuticals for its gelling properties. It serves as an excipient in drug delivery systems, particularly in capsules and microspheres. Gelatin's biocompatibility makes it suitable for various applications, including food products and pharmaceuticals, enhancing drug stabilization.
6) Science (Scientific):
Sciences encompass systematic study and understanding of the natural world through observation and experimentation. In the pharmaceutical context, particularly relevant fields include pharmacy, pharmacology, toxicology, and biochemistry, informing the development and application of medicinal products and therapeutic procedures.
7) Surface:
Surfaces pertain to the outer boundary or layer of materials. In the pharmaceutical context, surface properties of drugs and delivery systems can significantly influence interactions with biological membranes, influencing factors like absorption, drug release rates, and overall therapeutic effectiveness.
8) Patel:
Patel is a common surname in India and among the Indian diaspora. In the context of pharmaceutical literature, individuals with this surname may have contributed to research or development in areas like drug formulation or delivery systems. Their work typically encompasses improving therapeutic outcomes or exploring innovative solutions.
9) Table:
In scientific documents, a table is a structured format for presenting data and findings clearly and concisely. Tables can summarize research results, statistical analyses, comparisons, or classifications related to drug delivery systems or pharmacological studies, enhancing understanding and facilitating data interpretation.
10) Sharman (Sarma, Sharma, Sarman):
Sharma is a common Indian surname, often associated with individuals in various professions, including academia and pharmaceuticals. Researchers or authors with this surname may contribute to drug development, formulation science, or healthcare studies, advancing knowledge and innovation within the medical community.
11) Kumar:
Kumar is a widely used surname in India. In scientific research, many scholars and practitioners with this name have authored publications related to pharmaceuticals and therapeutics, often focusing on areas such as drug delivery systems, formulations, and pharmacokinetic studies, thus contributing to advancements in those fields.
12) Biodegradable:
Biodegradable materials can decompose through natural processes, reducing environmental impact. In pharmaceuticals, biodegradable polymers are increasingly used in drug delivery systems to ensure controlled release and minimal side effects. These materials dissolve over time, allowing for gradual drug release and lowering risks of toxicity.
13) Inflammation:
Inflammation is the body's protective response to injury or infection, characterized by redness, swelling, heat, and pain. It plays a crucial role in healing but can become problematic if chronic. Understanding inflammation mechanisms is vital for developing anti-inflammatory drugs and managing conditions like arthritis and IBD.
14) Relative:
The term 'relative' suggests a relationship or comparison between entities. In medical contexts, it often refers to assessments or evaluations in comparison to baseline measurements, aiding in understanding drug efficacy, patient response, or disease severity in relation to normative data.
15) Reason:
Reason refers to the rationale or justification behind actions, decisions, or phenomena. In healthcare, understanding the reasoning behind drug dosages, treatment plans, or epidemiological patterns is essential for effective patient management and informed clinical practices, ensuring evidence-based approaches to therapeutic solutions.
16) Indian:
The term 'Indian' denotes nationality or ethnic identity relating to India. It can also refer to the context of Indian traditional medicine or pharmaceuticals, which encompass a rich history of indigenous practices and herbal formulations that influence contemporary drug therapies and medical systems worldwide.
17) Blood:
Blood is a vital fluid in the human body, carrying oxygen and nutrients, and plays a crucial role in immune responses. In pharmacology, measuring blood parameters helps evaluate drug efficacy, toxicity, and therapeutic ranges, informing clinical decisions and the management of various medical conditions.
18) Pain:
Pain is a complex sensory and emotional experience, acting as a crucial signal of potential harm or injury. In healthcare, managing pain effectively is critical and becomes a focus in drug development, particularly for analgesics and anti-inflammatory medications to enhance patient quality of life.
19) Developing:
Developing refers to the process of creating or improving systems, products, or practices. In pharmaceuticals, developing new drugs encompasses research, formulation, safety assessments, and clinical trials, aiming to provide effective treatments that address medical needs and improve health outcomes for various conditions.
20) Activity:
Activity often refers to the effects or actions of a drug within biological systems. It can denote pharmacological efficacy, signaling pathways affected, or biological interactions with receptors. Understanding drug activity is fundamental in drug design and therapeutic interventions to treat diseases effectively.
21) Food:
Food is essential for sustenance and health, providing nutrients required for bodily functions. In pharmaceutical contexts, understanding food-drug interactions is crucial, as they can influence drug absorption, metabolism, and overall efficacy, impacting clinical guidelines for medication administration.
22) Hand:
In medical contexts, 'hand' may refer to manual techniques used for administering treatments or performing examinations. The dexterity and skillfulness of hands are important in various therapeutic procedures, ranging from surgical interventions to physical therapies, underscoring the need for trained healthcare professionals.
23) Pur:
The term 'poor' can describe suboptimal conditions, including health outcomes, access to healthcare, or drug effectiveness. In pharmaceuticals, addressing the challenges posed by poor drug solubility, bioavailability, or patient compliance is crucial for developing effective therapeutic interventions and enhancing public health.
24) Pharmacological:
Pharmacological pertains to the science of drugs, including their composition, uses, effects, and mechanisms of action within biological systems. This field is essential for understanding how drugs interact with the body, guiding effective treatment strategies and the management of various diseases.
25) Transformation (Transform, Transforming):
Transformation refers to a change in the state or structure of a substance. In pharmaceuticals, this term relates to drug metabolism and the physiological alterations that occur within the body after drug administration, influencing pharmacological effects and therapeutic outcomes.
26) Accumulation (Accumulating, Accumulate):
Accumulated refers to the collection or gradual increase of substances over time. In pharmacology, it may describe the buildup of drugs within the body, which can affect therapeutic outcomes and toxicity, necessitating careful monitoring during patient treatment regimens.
27) Substance:
Substances are distinct materials, which may include drugs, chemicals, or biological agents. In pharmaceutical contexts, understanding substances is essential in formulating, studying interactions, and assessing their benefits or risks within therapeutic applications, impacting drug safety and efficacy.
28) Toxicity:
Toxicity describes the degree to which a substance can cause harm or adverse effects in biological systems. In drug development, assessing toxicity is critical to ensure safety and efficacy, influencing dosage recommendations, risk management, and the overall design of therapeutic agents.
29) Entering:
Entering refers to the act of a substance moving into a particular area, often within biological systems. In pharmaceuticals, it describes the process of drug absorption and distribution into tissues, highlighting the importance of permeability and bioavailability metrics in therapeutic administration.
30) Species:
Species refers to distinct groups of organisms sharing common characteristics. In pharmacological contexts, understanding various species is vital for preclinical studies to predict human responses, as animal models can provide insights into drug safety and efficacy during the drug development process.
31) Ambala:
Ambala is a city in India, often mentioned in contexts related to local institutions, research, and pharmaceutical studies. It may house educational and pharmaceutical training institutes, contributing to the development of healthcare professionals and fostering advancements in the pharmaceutical industry.
32) Cancer:
Cancer encompasses a group of diseases characterized by uncontrolled cell growth. It poses significant challenges to public health and medicine. Research in drug delivery systems aimed at targeting cancerous cells or supporting chemotherapy regimens is an active area of pharmaceutical focus, improving treatment efficacy.
33) Powder:
Powder refers to a finely ground solid form, commonly used in pharmaceutical formulations. Powders can serve as active ingredients or excipients in drug delivery systems. They may influence solubility, stability, and release profiles, proving critical in creating effective medications.
34) Ulcer:
An ulcer is a break in the skin or mucous membrane, often painful and indicative of underlying issues such as infections or inflammation. Understanding the pathophysiology of ulcers is crucial for developing effective treatment and management strategies in clinical practice.
35) Gupta:
Gupta is a common surname in India, often associated with individuals in academic and research roles. Many researchers in pharmaceuticals, bearing this surname, contribute to advancements in drug formulation, delivery methodologies, and enhancing therapeutic interventions for various diseases.
36) India:
India is a country known for its rich tradition in medicine and pharmaceutical sciences. It plays a significant role in both traditional and modern medicinal practices, contributing to global healthcare through research, innovation, and production of a variety of pharmaceutical products.
37) Rich (Rch):
Rich generally describes a state of abundance or wealth. In medicinal contexts, it can pertain to the availability of resources, such as diverse compounds or traditional knowledge, which may facilitate drug development and enhance therapeutic options in healthcare practices.
38) Road:
In pharmaceutical literature, 'road' may refer to the metaphorical pathways or methodologies in drug development. It symbolizes the journey of translational research from basic science to clinical applications, emphasizing the complexity and iterative nature of creating effective therapies.
39) Line:
Line can denote a series or sequence in pharmaceutical studies, often referring to experimental approaches, treatment protocols, or development pathways. Understanding these lines aids in conceptually organizing research and facilitating methodical advancements in the pharmaceutical field.
40) Civilization:
Civilization denotes advanced social organization and development. In medical contexts, the evolution of civilization has profoundly influenced public health, medical practices, and pharmaceutical advancements, shaping the understanding and treatment of diseases throughout history and promoting global well-being.
41) Surrounding:
Surrounding relates to the environment or context around an object. In drug delivery research, understanding the surrounding factors, such as physiological conditions, local tissue properties, and interactions with biological systems is essential for optimizing drug formulations and achieving targeted delivery.
42) Discussion:
Discussion refers to the exchange of ideas, often in an academic context. In scientific research, discussions help elucidate findings, interpret results, and propose future research directions, enhancing understanding and fostering collaboration among experts in the pharmaceutical field.
43) Toxicology:
Toxicology is the study of the effects of substances on living organisms and the assessment of their hazardous effects. It is essential for evaluating the safety of drugs and chemicals, guiding regulatory approvals, and ensuring safe pharmaceutical practices in healthcare.
44) Irritation:
Irritation refers to discomfort or adverse reactions experienced due to exposure to stimuli, including external agents or medications. Understanding irritation is critical in drug development for creating formulations that minimize adverse effects and enhance patients' comfort and compliance.
45) Medicine:
Medicine is the field of health and healing, encompassing practices, interventions, and drug therapies aimed at preventing, diagnosing, and treating disease. It plays a crucial role in improving quality of life and health outcomes for individuals globally.
46) Swelling:
Swelling often refers to an increase in size due to fluid accumulation or tissue expansion. In pharmaceutical contexts, swelling can characterize responses in drug delivery systems, influencing drug release mechanisms and clinical outcomes by affecting absorption and therapeutic effectiveness.
47) Dressing:
Dressing refers to material applied to wounds for protection and healing. In healthcare, wound dressings can incorporate polymers or other materials to enhance healing processes. Understanding dressing technologies is important in designing effective treatment regimens for patients.
48) Bleeding:
Bleeding is the loss of blood from the circulatory system, often due to injuries or medical conditions. Managing bleeding is crucial in healthcare, with drug development focusing on agents that promote clotting or reduce excessive bleeding during surgical or traumatic incidents.
49) Gopinatha (Gopinath, Gopi-natha):
Gopinath is a common Indian surname, often associated with individuals in educational and research sectors. Researchers with this name may contribute to advancements in pharmaceuticals, particularly in drug formulation, delivery systems, and improving treatments for various illnesses.
50) Gayatri:
Gayatri is a popular name in India, often associated with individuals involved in academia or pharmaceutical research. The contributions from notable individuals with this name may focus on drug development, understanding pharmacodynamics, or creating innovative therapeutic solutions in healthcare.
51) Chandra:
Chandra is a common Indian surname, often relating to individuals in various fields, including medicine and pharmaceuticals. Those with this name may contribute to research and advancements in drug formulations, therapies, and medical practices aimed at enhancing patient care.
52) Quality:
Quality pertains to the standard of something, as measured against other similar things. In pharmaceuticals, quality control is essential for ensuring that medications are safe, effective, and manufactured according to strict regulatory guidelines, significantly impacting patient safety and therapeutic outcomes.
53) Account:
Account may refer to a detailed report or narrative explaining processes or events. In pharmaceuticals, it can denote documentation of drug development processes, research outcomes, and methodologies, facilitating transparency and understanding in the scientific and regulatory communities.
54) Kannaki:
Kannagi is a name associated with individuals in academic and research circles in India. Researchers with this name may contribute to advancements in drug delivery systems or other areas within pharmaceuticals, enhancing practices with innovative and effective solutions for healthcare challenges.
55) Company:
Company refers to a legal entity engaged in commercial, industrial, or professional activities. In the pharmaceutical industry, companies play a crucial role in drug development, marketing, and distribution, impacting health care availability and access to medications worldwide.
56) Pavani:
Pavani is a common name in India often associated with individuals engaged in various professional fields. Those with this name may contribute to research and practices in pharmaceutical science, enhancing understanding and innovation within drug development and delivery systems.
57) Brahma:
Brahma is a name often linked to individuals in Indian academia or research. In pharmaceuticals, researchers with this name may focus on advancing drug research, development practices, and exploring innovative therapeutic solutions to address health challenges.
58) Khatri:
Khatri is a common surname in India, often associated with individuals across various sectors, including medicine and pharmaceuticals. Researchers or professionals with this name may contribute to advancements in therapeutic practices, drug development, and healthcare quality.
59) Parikh:
Parikh is a common surname in India, often affiliated with professionals in the pharmaceutical and academic fields. Individuals with this name may be involved in research or development activities, contributing to innovations in drug delivery systems and therapeutic modalities.
60) Family:
Family refers to a group of related individuals. In the context of healthcare and pharmaceuticals, family history can influence drug responses and risks for diseases, guiding personalized medicine approaches and influencing treatment plans for patients.
61) Bitter:
Bitter describes a strong unpleasant taste that can deter medication adherence. In pharmaceuticals, masking bitterness through formulation strategies is critical to improve patient compliance, especially in oral medications, enhancing the overall therapeutic experience for patients.
62) Nature:
Nature signifies the physical world, including the flora and fauna, and the natural environment. In pharmaceutical contexts, understanding nature's role, including naturally derived compounds, is essential for drug discovery and developing therapies that leverage biological processes for improved health.
63) Animal:
Animal refers to multi-cellular organisms that are distinct from plants and fungi. In medical research, animal models play a critical role in preclinical studies, helping researchers understand disease mechanisms and evaluate drug safety and efficacy before human trials.
64) Killing (Killed):
Killed typically references the action of causing death or destruction. In the context of pharmaceuticals, killed may pertain to bacteria in the development of vaccines or treatments wherein pathogens are inactivated to elicit an immune response without causing disease.
65) Rajan:
Rajan is a common Indian name, often associated with individuals working in various fields. In pharmaceuticals, researchers with this name may be involved in drug formulation, development, or research contributing to advancements in healthcare solutions.
66) Delhi:
Delhi, the capital of India, is a significant hub for pharmaceutical research and development. Numerous pharmaceutical companies, research institutions, and academic programs are based here, facilitating advancements in drug development and enhancing healthcare services in the region.
67) Joshi (Josi):
Joshi is a common surname in India, frequently found among professionals in various domains, including pharmacy and healthcare. Individuals with this name may contribute to research and educational efforts, enhancing knowledge within pharmaceutical sciences and therapeutic advancements.
68) Culli:
Culli is a lesser-known term potentially connected to research or practices in niche areas of pharmaceuticals. Further context is essential to understand its specific relevance and impact in drug development or healthcare discussions.
69) Malik:
Malik is a common Indian surname. In pharmaceutical research, individuals with this surname may contribute insights to areas such as drug development, formulation science, or public health, playing roles in advancing healthcare and therapeutic solutions.
70) Raval:
Raval is a common name in India, often found among professionals engaged in academia or pharmaceuticals. Those with this name may focus their research efforts on drug formulation, innovative delivery systems, or the pharmacological effects of various substances.
71) Kadam:
Kadam is a surname often associated with individuals engaged in various fields, including medicine and research. In pharmaceutical contexts, those with this name may contribute to advancements in drug delivery systems and therapeutic solutions, enhancing patient outcomes.
72) Field:
Field refers to a particular area of study or professional activity. In pharmaceuticals, specialized fields include pharmacology, toxicology, and drug formulation science, with ongoing research crucial for innovation and improving healthcare outcomes.
73) Pulse:
Pulse can refer to a rhythmic expansion and contraction, often associated with blood flow but also used in drug delivery systems. It may represent controlled release mechanisms that mimic physiological processes to optimize therapeutic outcomes.
74) Study (Studying):
Study refers to the process of examining and analyzing data to gain insights. In pharmaceuticals, rigorous studies underpin drug development, efficacy assessment, and safety evaluations, critical for regulatory approval and clinical practice implementation.
75) Rama:
Rama is a common name in India, often associated with individuals in various fields, including academics and pharmaceuticals. Those with this name may contribute to research efforts in pharmaceutical sciences, enhancing treatments and therapies.
[Note: The above list is limited to 75. Total glossary definitions available: 83]